| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $39,071,980 ) (Continued on the next page) |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01HL161008 | Biomarker-guided optimization of transcutaneous vagal stimulation for atrial fibrillation | 001 | 2 | NIH | 3/10/2023 | $39,102 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21CA271218 | Non-invasive assessment of graft vs host disease using optoacoustic imaging | 000 | 1 | NIH | 12/23/2022 | $169,469 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK133207 | ROCK, tight junctions and prematurity in the pathogenesis of necrotizing enterocolitis and neonatal sepsis. | 000 | 1 | NIH | 3/20/2023 | $528,053 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01HL161008 | Biomarker-guided optimization of transcutaneous vagal stimulation for atrial fibrillation | 000 | 2 | NIH | 1/14/2023 | $351,926 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | K01DA055073 | Identifying and Addressing the Effects of Social Media Use on Young Adults' E-Cigarette Use: A Solutions-Oriented Approach | 000 | 1 | NIH | 2/1/2023 | $183,979 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R56AI174413 | Low density neutrophils and lupus | 000 | 1 | NIH | 12/8/2022 | $362,500 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DA053342 | Beta-Adrenergic Modulation of Drug Cue Reactivity: Neural and Behavioral Mechanisms | 000 | 2 | NIH | 3/22/2023 | $488,732 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H79SM085083 | Stronger Together: Attachment, Resilience, & Support (STARS): Helping Children and Youth Reach Their Full Potential | 001 | 1 | SAMHSA | 2/24/2023 | $0 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F31DK130605 | WNT signaling in Autosomal Dominant Polycystic Kidney Disease | 001 | 2 | NIH | 2/10/2023 | $942 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H79SM085083 | Stronger Together: Attachment, Resilience, & Support (STARS): Helping Children and Youth Reach Their Full Potential | 001 | 1 | SAMHSA | 2/24/2023 | $0 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H79SM085083 | Stronger Together: Attachment, Resilience, & Support (STARS): Helping Children and Youth Reach Their Full Potential | 000 | 1 | SAMHSA | 11/30/2022 | $600,000 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H79SM085083 | Stronger Together: Attachment, Resilience, & Support (STARS): Helping Children and Youth Reach Their Full Potential | 000 | 1 | SAMHSA | 11/30/2022 | $600,000 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA247234 | Role of Zinc Dependent EMT-Transcription Factors (EMT-TF) in Pancreatic Cancer Metastasis | 000 | 4 | NIH | 5/31/2023 | $325,054 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK117965 | Regulation of Bile Acid Metabolism and Signaling in Metabolic Diseases | 001 | 5 | NIH | 1/5/2023 | $28,597 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | P20GM103447 | Enhancing OK-INBRE Research Partnerships with COBRE Programs in Oklahoma | 001 | 24 | NIH | 5/10/2023 | $3,561,212 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AI154274 | Cellular Mechanism of Oxysterol-Binding Protein (OSBP) in Viral Proliferation: A Chemical Biology Approach | 002 | 3 | NIH | 5/16/2023 | $33,183 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA233613 | Role of the DNPH1 Enzyme in Breast Cancer | 000 | 5 | NIH | 2/2/2023 | $350,063 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 Research Pkwy Ste 530 | Oklahoma City | OK | 73104-3609 | OKLAHOMA | USA | U1Q33082 | Geriatrics Workforce Enhancement Program | 00 | 5 | HRSA | 4/21/2023 | $749,541 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AI154274 | Cellular Mechanism of Oxysterol-Binding Protein (OSBP) in Viral Proliferation: A Chemical Biology Approach | 001 | 3 | NIH | 3/16/2023 | $399,717 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AI154274 | Cellular Mechanism of Oxysterol-Binding Protein (OSBP) in Viral Proliferation: A Chemical Biology Approach | 000 | 2 | NIH | 12/22/2022 | $34,831 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | K01DK119375 | Investigating CD4 T regulatory cells during rapid cystogenesis | 000 | 4 | NIH | 5/8/2023 | $151,664 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 Research Pkwy Ste 530 | Oklahoma City | OK | 73104-3609 | OKLAHOMA | USA | UH735353 | Regional Genetics Networks | 00 | 4 | HRSA | 4/6/2023 | $363,637 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA233201 | An improved IL-24 gene-based therapeutic for cancer | 001 | 5 | NIH | 3/15/2023 | $28,075 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R37AI037657 | Pore Formation by Cholesterol Dependent Cytolysins | 000 | 27 | NIH | 3/21/2023 | $475,153 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA251451 | Mobile Contingency Management for Smoking Cessation among Socioeconomically Disadvantaged Adults | 000 | 3 | NIH | 3/29/2023 | $596,014 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01HL152205 | A cardiac Wingless-Snail-Tep2 axis directs normal lipid homeostasis and protects against diet-induced obesity | 000 | 4 | NIH | 3/13/2023 | $362,500 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK119125 | Amygdala Mediated Mechanisms Regulating Visceral Pain | 000 | 4 | NIH | 1/27/2023 | $326,250 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA233201 | An improved IL-24 gene-based therapeutic for cancer | 000 | 5 | NIH | 12/26/2022 | $315,846 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK126705 | Ciliary Disassembly, a modifier of Autosomal Dominant Polycystic Kidney Disease | 000 | 3 | NIH | 1/18/2023 | $356,307 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | P20GM134973 | Oklahoma Center for Microbial Pathogenesis and Immunity | 000 | 4 | NIH | 3/3/2023 | $2,157,378 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA221819 | Smartphone Based Smoking Cessation Intervention for Socioeconomically Disadvantaged Adults | 000 | 5 | NIH | 2/1/2023 | $467,627 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01EY026999 | Aberrant RPE mTORC1 signaling in dysregulation of choroid homeostasis | 002 | 7 | NIH | 4/25/2023 | $362,500 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA253391 | Normalizing aberrant metabolism in ovarian cancer by a unique drug delivery system | 000 | 3 | NIH | 2/6/2023 | $376,116 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | P30CA225520 | Stephenson Cancer Center - Cancer Center Support Grant | 000 | 6 | NIH | 5/8/2023 | $2,040,621 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA255840 | Chemotherapy-induced vascular cognitive impairment: role of endothelial senescence | 000 | 3 | NIH | 2/9/2023 | $325,054 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA230641 | Microbiome-triggered reprogramming and mutation of colon epithelial cells leading to tumor stem-like cells | 000 | 5 | NIH | 2/23/2023 | $421,648 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F31DK130605 | WNT signaling in Autosomal Dominant Polycystic Kidney Disease | 000 | 2 | NIH | 1/31/2023 | $34,815 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK121951 | Role of the Macrophage in Developmentally Programmed NAFLD | 001 | 4 | NIH | 5/26/2023 | $511,811 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AI119048 | Differential Effects of TcdB1 and TcdB2 in C. difficile disease | 000 | 9 | NIH | 1/12/2023 | $432,300 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T03OH008614 | Training for Industrial Hygiene Professionals and Researchers | 00 | 20 | CDC | 6/6/2023 | $50,000 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK131064 | Sulfur Amino Acid Metabolism and Regulation of Hepatic Metabolic Flexibility | 000 | 2 | NIH | 1/12/2023 | $412,123 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 Research Pkwy Ste 530 | Oklahoma City | OK | 73104-3609 | OKLAHOMA | USA | H7600185 | Ryan White Part C Outpatient EIS Program | 01 | 27 | HRSA | 4/18/2023 | $495,838 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 Research Pkwy Ste 530 | Oklahoma City | OK | 73104-3609 | OKLAHOMA | USA | H7600185 | Ryan White Part C Outpatient EIS Program | 00 | 27 | HRSA | 12/2/2022 | $354,218 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AG070915 | The role of IGF-1 signaling in vascular smooth muscle cells in age-related vascular cognitive impairment and dementia | 000 | 3 | NIH | 5/16/2023 | $357,100 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AG059718 | The Role of Necroptosis in Aging | 000 | 5 | NIH | 1/24/2023 | $321,393 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA225439 | Tribally Engaged Approaches to Lung Screening (TEALS) | 001 | 4 | NIH | 3/14/2023 | $38,636 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H79SM083028 | SAMHSA's Suicide Prevention Resource Center grant. | 001 | 3 | SAMHSA | 12/22/2022 | $6,505,128 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T7300033 | OKLAHOMA LEND: MCH INTERDISCIPLINARY LEADERSHIP GRANT | 00 | 27 | HRSA | 5/19/2023 | $644,681 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | UG1CA233193 | A Lead Academic Participating Site in Oklahoma for the Design and Conduct of NCTN Clinical Trials | 000 | 5 | NIH | 2/16/2023 | $1,871,024 |
|
